Author:
Higgins Jake,Brogley Michele,Palanisamy Nallasivam,Mehra Rohit,Ittmann Michael M.,Li Jun Z.,Tomlins Scott A.,Robins Diane M.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Endocrine and Autonomic Systems,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism
Reference86 articles.
1. Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, Borowsky AD, Cardiff RD, Shen MM (2003) Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res 63(14):3886–3890
2. Abate-Shen C, Shen MM (2000) Molecular genetics of prostate cancer. Genes Dev 14(19):2410–2434
3. Albertelli MA, O’Mahony OA, Brogley M, Tosoian J, Steinkamp M, Daignault S, Wojno K, Robins DM (2008) Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice. Hum Mol Genet 17(1):98–110. doi:10.1093/hmg/ddm287
4. Albertelli MA, Scheller A, Brogley M, Robins DM (2006) Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 20(6):1248–1260. doi:10.1210/me.2006-0021
5. Alimonti A, Carracedo A, Clohessy JG, Trotman LC, Nardella C, Egia A, Salmena L et al (2010) Subtle variations in Pten dose determine cancer susceptibility. Nat Genet 42(5):454–458. doi:10.1038/ng.556
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献